Dr. Laurie Mereu is currently appointed as Professor in the Division of Endocrinology & Metabolism in the Faculty of Medicine and Dentistry.
Diabetes, double blind randomized placebo controlled trial e
A 28-week, prospective, single-arm, open label phase 4 study to evaluate treatment optimization with once-daily insulin glargine hoe901-300 iu/ml in combination with prandial rapid-acting insulin analogue in patients with type 1 diabetes previously uncontrolled on twice daily basal insulin as part of basal-bolus therapy.
- Funding Source: Sanofi
- Year Granted: 2017